These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25837834)

  • 21. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.
    Guns PJ; Korda A; Crauwels HM; Van Assche T; Robaye B; Boeynaems JM; Bult H
    Br J Pharmacol; 2005 Sep; 146(2):288-95. PubMed ID: 15997227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G protein-coupled purinergic P2Y receptor oligomerization: Pharmacological changes and dynamic regulation.
    Guo X; Li Q; Pi S; Xia Y; Mao L
    Biochem Pharmacol; 2021 Oct; 192():114689. PubMed ID: 34274353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.
    Woods LT; Forti KM; Shanbhag VC; Camden JM; Weisman GA
    Biochem Pharmacol; 2021 May; 187():114406. PubMed ID: 33412103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
    Yelovitch S; Camden J; Weisman GA; Fischer B
    J Med Chem; 2012 Jan; 55(1):437-48. PubMed ID: 22107038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reviewing the role of P2Y receptors in specific gastrointestinal cancers.
    Bellefeuille SD; Molle CM; Gendron FP
    Purinergic Signal; 2019 Dec; 15(4):451-463. PubMed ID: 31478181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a carbohydrate recognition motif of purinergic receptors.
    Zhao L; Wei F; He X; Dai A; Yang D; Jiang H; Wen L; Cheng X
    Elife; 2023 Nov; 12():. PubMed ID: 37955640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
    Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
    J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.
    Trujillo K; Paoletta S; Kiselev E; Jacobson KA
    Bioorg Med Chem; 2015 Jul; 23(14):4056-64. PubMed ID: 25868749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
    El-Tayeb A; Qi A; Müller CE
    J Med Chem; 2006 Nov; 49(24):7076-87. PubMed ID: 17125260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.
    Alves M; Gomez-Villafuertes R; Delanty N; Farrell MA; O'Brien DF; Miras-Portugal MT; Hernandez MD; Henshall DC; Engel T
    Epilepsia; 2017 Sep; 58(9):1603-1614. PubMed ID: 28733972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design.
    Salmaso V; Jacobson KA
    ChemMedChem; 2020 Nov; 15(21):1958-1973. PubMed ID: 32803849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purinergic receptors in human placenta: evidence for functionally active P2X4, P2X7, P2Y2, and P2Y6.
    Roberts VH; Greenwood SL; Elliott AC; Sibley CP; Waters LH
    Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1374-86. PubMed ID: 16373435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P2Y
    Communi D; Horckmans M; Boeynaems JM
    Biochem Pharmacol; 2021 May; 187():114347. PubMed ID: 33232731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coupling of P2Y receptors to G proteins and other signaling pathways.
    Erb L; Weisman GA
    Wiley Interdiscip Rev Membr Transp Signal; 2012; 1(6):789-803. PubMed ID: 25774333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
    Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK
    Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors.
    Mamedova L; Capra V; Accomazzo MR; Gao ZG; Ferrario S; Fumagalli M; Abbracchio MP; Rovati GE; Jacobson KA
    Biochem Pharmacol; 2005 Dec; 71(1-2):115-25. PubMed ID: 16280122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular Nucleotides Selectively Induce Migration of Chondrocytes and Expression of Type II Collagen.
    Szustak M; Gendaszewska-Darmach E
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Structure of P2Y Receptors: Mutagenesis, Modeling, and Chemical Probes.
    Jacobson KA; Jayasekara MP; Costanzi S
    Wiley Interdiscip Rev Membr Transp Signal; 2012 Sep; 1(6):. PubMed ID: 23336097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing GPCR structure: adenosine and P2Y nucleotide receptors.
    Jacobson KA; Costanzi S; Deflorian F
    Methods Enzymol; 2013; 520():199-217. PubMed ID: 23332701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.